Q1 FY26 results filed; board approves 150 crore guarantee for BSV subsidiary

Emphasis Of MatterResults RestatedExceptional ItemRelated Party TransactionsContingent Liabilities IncreasedResults View source PDF Explain this filing

MANKIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.8%Reaction day

₹2569.90

prior close

₹2604.00

announcement price

After-mkt

timing

Nifty Midcap 150market+0.5%-4.3% vs market

Pharmaceuticals peers, median of 164sector+0.1%-3.9% vs sector

On the reaction day the stock moved 4.3 pts less than Nifty Midcap 150 and 3.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-5.2

10m

-5.8

15m

-5.1

30m

-5.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.8+0.5-4.3+0.1-3.9

Next day

-3.4+1.7-5.1+1.1-4.5

-4.5+1.4-5.8+1.0-5.5

-5.1+1.6-6.7+1.1-6.2

-5.8+1.2-7.0+1.2-7.0

-4.5+1.4-5.9+1.5-6.0

-5.5+1.9-7.4+2.3-7.8

15d

-7.2+1.6-8.9+1.3-8.6

-5.9+2.2-8.1+2.3-8.2

-2.6-5.1+2.5+3.2-5.7

—————

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mankind Pharma Q1 FY26 standalone revenue Rs 2,964 crore (up 14.8% YoY), consolidated Rs 4,031 crore (up 12.9% YoY). Standalone PAT Rs 558 crore versus Rs 714 crore in Q1 FY25 (restated). Consolidated PAT rose to Rs 574 crore. Board approved Rs 150 crore corporate guarantee for wholly owned BSV subsidiary for bank credit. Sold Broadway Hospitality subsidiary for Rs 49 crore.

Likely market impact

Mixed Q1 results; consolidated profit up but standalone PAT fell. Guarantee adds contingent liability. Income tax dispute of around 1,869 crore pending.